MedicNEWS for October 2025
In This Issue
🩺 Editorial: The Heat, the Hurt, and the Hype
Acetaminophen is in the spotlight. We unpack the recent misinformation linking it to autism, revisit the real evidence, and share how paramedics can help patients make informed choices. Don’t miss our “Cones & Fins” visual explainer on correlation vs. causation.
🎓 Continuing Education: Critical Interventions, Critical Thinking
Fall CME is underway! This season’s focus — from emergency childbirth to medication safety — brings new opportunities to refine your clinical skills and strengthen critical thinking. Nearly 400 paramedics are already on board.
đź’ˇ Elective CME
Airway Day is back, and Trauma Days return with Eric Gagnon. See what’s coming up in RPPEO’s education lineup and register early for credit.
đź“° News Nuggets: Quick reads, deep insights
- “Faster Ambulances” — what Ontario’s funding boost really means for patient care.
- International Paramedic Exchange — Australia to U.S. pathways open.
⚕️ Medical Direction
Regional Measles Watch: A few cases, no clusters — stay alert and check your MMR status.
Methoxyflurane Update: Research complete; future use under review pending approvals and audit capacity.
👩⚕️ BHP Corner: Managing Anaphylaxis — Pediatric Focus
When every second counts, know the difference between improvement and danger. Dr. Sara-Pier Piscopo explores why epinephrine remains the cornerstone of anaphylaxis management.
❤️ Quality & Patient Safety: Who Speaks for the Patient?
In emergencies, conflicting voices can make decision-making complex. Charlene Vacon explores substitute decision makers (SDMs), consent, and the legal hierarchy guiding patient-centered care.
🔬 Research Science: Ten Studies That Matter
From 12-lead ECG use in ACS to airway success rates and trauma line feasibility — ten recent studies every paramedic should know. Concise, relevant, and ready for practice.
As always, if you’ve come across clinical insights or stories worth sharing, send them to info@RPPEO.ca with "MedicNEWS" in the subject line. We love hearing from you. Enjoy the issue!